Abstract:Background Melanocytic tumors driven by MAP2K1 in‐frame deletions are among the most recently described class of melanocytic neoplasms. The reported range of diagnoses and associated genomic aberrations in these neoplasms is wide and includes melanomas, deep penetrating melanocytomas, and pigmented epithelioid melanocytoma. However, little is known about the characteristics of these tumors, especially in the absence of well‐known second molecular "hits." Moreover, despite their frequent spitzoid cytomorphology, their potential categorization among the Spitz tumors is debatable. Materials and Methods We conducted a retrospective search through our molecular archives to identify sequenced melanocytic tumors with MAP2K1 in‐frame deletions. We reviewed the clinical and histomorphological features of these tumors and compared them to similar neoplasms reported to date. In addition, we performed single‐nucleotide polymorphism (SNP) array testing to identify structural chromosomal aberrations. Results Of 27 sequenced tumors, 6 (22%) showed a pathogenic MAP2K1 in‐frame deletion (with or without insertion) and were included in this series. Five (83%) were females with lesions involving the upper limb. Histopathologically, all neoplasms were compounded with plaque‐like or wedge‐shaped silhouettes, spitzoid cytomorphology, and impaired cytologic maturation. All cases showed background actinic damage with sclerotic stroma replacing solar elastosis, variable pagetoid scatter, and occasional dermal mitotic figures (range 1–2/mm2). Five cases (83%) had a small component of nevic‐looking melanocytes. Biologically, these tumors likely fall within the spectrum of unusual nevi. Five cases (83%) had a relatively high mutational burden and four (67%) showed an ultraviolet radiation signature. Four cases (67%) showed in‐frame deletion involving the p.I103_K104del locus while two cases (33%) showed in‐frame deletion involving the p.Q58_E62del locus. SNP array testing showed structural abnormalities ranging from 1 to 5 per case. Five of these cases showed a gain of chromosome 15 spanning the MAP2K1 gene locus. Discussion and Conclusion Melanocytic tumors with MAP2K1 in‐frame deletion could represent another spectrum of melanocytic tumors with close genotypic–phenotypic correlation. They are largely characterized by a spectrum that encompasses desmoplastic Spitz nevus as shown in our series and Spitz and Clark nevus as shown by others. Evolutionary, they share many similarities with tumors with BRAF V600E mutations, suggesting they are better classified along the conventional pathway rather than the Spitz pathway despite the frequent spitzoid morphology.

Pigmented trichoblastoma developed in a sebaceous nevus: HRAS mutation as a common molecular driver

Genetic analyses of a secondary poroma and trichoblastoma in a HRAS-mutated sebaceous nevus

Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell

The first case of Chinese phacomatosis pigmentokeratotica diagnosed by a missense HRAS mosaicism

Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome

NRASQ61R-driven atypical melanocytic tumor with blue nevus-like morphology: A case report

Pigmented Trichoepitheliomas, Not an Uncommon Variant: A Dermoscopical Insight

MAP2K1‐mutated melanocytic tumors have reproducible histopathologic features and share similarities with melanocytic tumors with BRAF V600E mutations

Somatic KRAS mutation affecting codon 146 in linear sebaceous nevus syndrome

Mosaic RASopathies concept: different skin lesions, same systemic manifestations?

A suspicious mole under the knee

Identification of KRAS mutation in a patient with linear nevus sebaceous syndrome: a case report

Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma

Pigmented plexiform neurofibroma: Distinction from a large congenital melanocytic nevus

Concomitant BRAF V600E and NRAS Q61R mutations in the same thyroid nodule: a case report

Primary cutaneous apocrine carcinoma with RARA::NPEPPS fusion

Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review

Malignant Melanoma with Atypical Phenotype and RAC1 Mutation

Phacomatosis spilosebacea: A new name for a distinctive binary genodermatosis

Is Schimmelpenning Syndrome Associated with Intracranial Tumors? A Case Report

Molecular characterization of biphenotypic epithelioid and plexiform melanoma with deep penetrating nevus-like features